From DOTS to DOST: a new framework for TB elimination in India
India bears a quarter of the global tuberculosis (TB) burden and nearly one-third of TB related deaths, but substantial regional heterogeneity demands tailored elimination strategies. We propose the Dual-phase Operational Strategy for Tuberculosis elimination (DOST), a roadmap that explicitly addresses TB as both an infectious disease and a structural challenge. Phase 1 focuses on rapidly reducing transmission through intensified case-finding, upfront molecular diagnosis, and strengthened treatment, as demonstrated by India's 100-Day TB Campaign, which expanded community screening and accelerated therapy initiation. Phase 2 pivots to preventing disease progression by scaling up TB preventive treatment and addressing key drivers such as undernutrition, HIV, and diabetes. DOST emphasizes subnational adaptation: high-burden states prioritize disease reduction, while states nearing low incidence shift toward preventing flare-ups and sustaining progress. Rooted in the Hindi word dost (friend), this person-centered approach integrates medical and social support, recognizing that eliminating TB in India requires compassion paired with structural action. By sequencing and localizing proven interventions, DOST offers a pragmatic pathway from TB response to TB elimination.
Authors
- Vinay Garg
- Sanjay Kumar Mattoo (ORCID: https://orcid.org/0000-0001-9711-321X)
- R. Rao
- Madolyn Rose Dauphinais (ORCID: https://orcid.org/0000-0003-4319-9788)
- Nishant Kumar
- Sadie Cowan
- Amar Shah
- Shivani Chandra
- Urvashi B. Singh
- Pranay Sinha
- Veena Dhawan
- Kiran Rade
Institutions
- New Delhi Tuberculosis Center (IN)
- World Health Organization - India (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- The Lancet Regional Health - Southeast Asia
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1016/j.lansea.2026.100721
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 32.78